Amerikanische Gesellschaft für Hirudotherapie

Evaluation and Management of Mechanical Heart Valve Dysfunction and Thrombosis.

Review published in Current cardiology reports (2024)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewKlinische StudienArzneimittelentwicklungParizher et al. · Current cardiology reports, 2024

Abstract

PURPOSE OF REVIEW: Dysfunction and thrombosis of mechanical heart valves, although uncommon, represents a challenge that requires multidisciplinary expertise for diagnosis and management. The aim of this review is to summarize strengths and weaknesses of diagnostic methods and therapeutic strategies for this uncommon but potentially life-threatening pathology. RECENT FINDINGS: Expeditious diagnosis of mechanical valve thrombosis and exclusion of other diagnostic considerations, often with incorporation of multimodality imaging, can inform the best treatment strategy. Presentation of mechanical valve thrombosis can be asymptomatic or can include heart failure, life-threatening embolic events, or cardiogenic shock. Echocardiography, fluoroscopy and computed tomography are important in the evaluation of mechanical valve dysfunction. Therapeutic strategies for thrombosis include anticoagulation, systemic thrombolysis, and surgery. Choice of treatment depends on multiple factors including thrombus size, degree of valve dysfunction, clinical presentation, and available surgical expertise.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsHumansThrombosisHeart Valve ProsthesisThrombolytic TherapyAnticoagulantsEchocardiographyHeart Valve DiseasesProsthesis FailureTomography, X-Ray Computed

Zusammenfassung

Dysfunction and thrombosis of mechanical heart valves, although uncommon, represents a challenge that requires multidisciplinary expertise for diagnosis and management. The aim of this review is to summarize strengths and weaknesses of diagnostic methods and therapeutic strategies for this uncommon...

Warum dies für die Hirudotherapie relevant ist

This review summarizes the diagnostic methods and therapeutic strategies, including anticoagulation and systemic thrombolysis, used to manage mechanical heart valve dysfunction and thrombosis. Because mechanical valve thrombosis is a life-threatening condition driven by pathological coagulation, understanding the current standards for systemic anticoagulation provides important context for the broader field of hemostasis and thrombosis management where leech-derived anticoagulants operate. The relevance to the American Society of Hirudotherapy is entirely indirect. The abstract focuses purely on conventional pharmacological interventions, multimodality imaging, and surgical decision-making, and it does not evaluate leech therapy, hirudin, or any components of the leech secretome.

Zitation

Evaluation and Management of Mechanical Heart Valve Dysfunction and Thrombosis.

Parizher et al. · Current cardiology reports, 2024

Verwandter klinischer Kontext

Zur ASH-Bibliothek hinzugefügt: May 28, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.